Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucosamine sulfate potassium chloride is a stabilized salt complex of glucosamine, a naturally occurring amino sugar that serves as a fundamental building block for the biosynthesis of glycosaminoglycans and proteoglycans. These compounds are essential components of the cartilage matrix and synovial fluid. Exogenous administration of this compound is intended to stimulate cartilage repair, inhibit degradative enzymes, and exert mild anti-inflammatory effects, thereby alleviating pain and improving joint function in patients with osteoarthritis. The inclusion of potassium chloride in the formulation serves to stabilize the glucosamine sulfate molecule, which is otherwise highly hygroscopic and chemically unstable. It is widely utilized both as a pharmaceutical agent in various international markets and as a dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucosamine sulfate potassium chloride.